发明名称 NEW VITRO ALPHATIC COMPOUNDS
摘要 A compound of the formula or its pharmaceutically acceptable salt: …<CHEM>… wherein… R<1> is hydrogen, lower alkyl or lower alkoxylphenyl,… R<2> is hydrogen or lower alkyl,… R<3> and R<5> are each hydrogen, or together to form a bond for getting a group of the formula: …<CHEM>… wherein R<4> and R<6> are each as defined below,… R<4> is lower alkyl,… R<6> is hydrogen or lower alkyl,… R<7> is hydrogen or a certain group, and… R<1><0> is hydrogen or lower alkyl which may have carboxy or esterified carboxy, processes for its preparation and pharmaceutical compositions containing it as an effective ingredient.
申请公布号 AU2174483(A) 申请公布日期 1984.07.05
申请号 AU19830021744 申请日期 1983.11.28
申请人 FUJISAWA PHARMACEUTICAL CO., LTD. 发明人 MASANORI OKAMOTO;SHIGEHIRO TAKASE;KAZUYOSHI UMEHARA;HIROSHI IMANAKA;MORITA IWAMI;ITSUO UCHIDA;MASANOBU KOHSAKA
分类号 C07D207/416;A61K31/15;A61K31/16;A61K31/215;A61K31/26;A61K31/445;A61K31/495;A61P7/02;A61P9/08;A61P9/12;C07C43/23;C07C45/41;C07C57/03;C07C205/51;C07C233/02;C07C233/09;C07C233/20;C07C233/49;C07C235/28;C07C249/04;C07C251/32;C07C251/38;C07C251/40;C07C251/60;C07C255/10;C07C255/19;C07C255/23;C07C255/64;C07C291/12;C07D207/40;C07D207/404;C07D295/18;C07D295/185 主分类号 C07D207/416
代理机构 代理人
主权项
地址